Formulation and evaluation of multilamellar vesicles ropivacaine in pain management
Hao-Wen Kao,1 Yi-Yu Lin,1 Walter J Gwathney,1 Keelung Hong1,2 1TLC Biopharmaceuticals, Inc., South San Francisco, CA 94080, USA; 2Taiwan Liposome Company, Ltd., Taipei 11503, TaiwanCorrespondence: Yi-Yu LinTLC Biopharmaceuticals, Inc., South San Francisco, CA 94080, USATel +1 650 872 8816Fax +1 650...
Enregistré dans:
Auteurs principaux: | Kao HW, Lin YY, Gwathney WJ, Hong K |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Dove Medical Press
2019
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/d6f1b88b9cde4917ab2fe967f537c2aa |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|
Documents similaires
-
An efficient and long-acting local anesthetic: ropivacaine-loaded lipid-polymer hybrid nanoparticles for the control of pain
par: Li A, et autres
Publié: (2019) -
Long-term effect of ropivacaine nanoparticles for sciatic nerve block on postoperative pain in rats
par: Wang Z, et autres
Publié: (2016) -
Ropivacaine: An Unusual Cause of Neuroleptic Malignant-Like Syndrome
par: Miguel Santos, et autres
Publié: (2021) -
Supraclavicular block with Mepivacaine vs Ropivacaine, their impact on postoperative pain: a prospective randomised study
par: Irén Sellbrant, et autres
Publié: (2021) -
Circadian Variation in the Median Effective Dose of Epidural Ropivacaine for Labor Analgesia
par: Jiali Deng, et autres
Publié: (2021)